Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Deslorelin with Add-back Hormones for Breast Cancer Prevention in BRCA Carriers
NCT00080756Phase 2Active, not recruiting
- Sponsor
- City of Hope
- Start
- Mar 2004
- Primary completion
- Sep 2024
- Modality
- Peptides
- Countries
- 1
01
Overview
A Phase 2 trial of deslorelin in breast cancer, sponsored by City of Hope. Started Mar 2004; status: active, not recruiting.
02
Drugs
deslorelin
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT00080756.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00080756.